Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease

Olga Nardone, Marietta Iaccuci, Subrata Ghosh, Fabiana Castiglione

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)
184 Downloads (Pure)


Transition care in inflammatory bowel disease is increasingly recognized as challenging given the inherent differences between paediatric and adult health care models, disease characteristics and treatment strategies. Transition is a dynamic process involving adolescents and young adults that are moving from a paediatric to an adult health care setting, and it should be flexible, continually updated and tailored to each patient. The implementation of a transition clinic is essential given the increasing incidence of the paediatric population with inflammatory bowel disease and the lifelong impact of this disease.

The key question is when and how to structure transition according to the adolescent's clinical, psycho-social, educational needs and expectations to ensure continuity of care.

In the attempt to improve the management of transition in inflammatory bowel disease and address the wide gap between adult and child care, we provide an update of the transition clinic and we propose a “treat to target” approach in transition to facilitate an effective and successful transition programme. In the changing landscape of the treatment of inflammatory bowel disease, further studies are necessary to determine the role of the transition clinic in determining the choice and strategy of therapy and its monitoring and the adoption of newer strategies such as biomarkers guided treating to target.
Original languageEnglish
Pages (from-to)516-527
Number of pages12
JournalDigestive and Liver Disease
Issue number5
Early online date28 Mar 2020
Publication statusPublished - May 2020


  • Children
  • Crohn’s disease
  • Healthcare
  • Ulcerative colitis


Dive into the research topics of 'Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this